Thurston Springer Miller Herd & Titak Inc. Sells 2,589 Shares of Intuitive Surgical, Inc. $ISRG

Thurston Springer Miller Herd & Titak Inc. decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 92.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 221 shares of the medical equipment provider’s stock after selling 2,589 shares during the period. Thurston Springer Miller Herd & Titak Inc.’s holdings in Intuitive Surgical were worth $99,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Norway Savings Bank increased its position in shares of Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares during the last quarter. Trust Co. of Oklahoma purchased a new position in Intuitive Surgical in the second quarter worth $363,000. IronOak Wealth LLC. bought a new position in Intuitive Surgical in the 2nd quarter valued at $1,099,000. Eastover Investment Advisors LLC grew its stake in Intuitive Surgical by 204.8% in the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after purchasing an additional 8,844 shares during the period. Finally, Amalgamated Bank increased its position in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after purchasing an additional 1,772 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary S. Guthart sold 28,800 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the transaction, the insider directly owned 27,027 shares of the company’s stock, valued at $14,798,904.12. The trade was a 51.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 114,007 shares of company stock valued at $63,533,844 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of research analyst reports. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research note on Wednesday. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Rothschild & Co Redburn lifted their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Finally, Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $609.83.

Intuitive Surgical Trading Up 0.4%

Shares of ISRG stock opened at $556.86 on Thursday. The firm’s 50 day moving average is $536.26 and its 200 day moving average is $505.77. The stock has a market capitalization of $199.62 billion, a P/E ratio of 73.66, a PEG ratio of 5.10 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the business earned $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.